AcelRx Pharmaceuticals Inc (ACRX) Stock: Do Analysts Think You Should Hold?

Wednesday, December 14, 2022 01:37 PM | InvestorsObserver Analysts

Mentioned in this article

AcelRx Pharmaceuticals Inc (ACRX) Stock: Do Analysts Think You Should Hold?

Wall Street is positive on AcelRx Pharmaceuticals Inc (ACRX). On average, analysts give ACRX a Buy rating. The average price target is $80, which means analysts expect the stock to add by 3037.25% over the next twelve months. That average ranking earns ACRX an Analyst Rating of 35, which is better than 35% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating ACRX a Buy today. Find out what this means to you and get the rest of the rankings on ACRX!

See Full ACRX Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With AcelRx Pharmaceuticals Inc Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock is trading at $2.55 as of 1:17 PM on Wednesday, Dec 14, a rise of $0.15, or 6.25% from the previous closing price of $2.40. The stock has traded between $2.41 and $2.60 so far today. Volume today is light. So far 102,456 shares have traded compared to average volume of 165,351 shares. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.